[ET Net News Agency, 26 January 2022] INNOVENT BIO (01801) fell 5.26% to HK$38.75.
It hits an intra-day low of HK$38.7, and an intra-day high of HK$42.25. The total shares
traded was 2.56 million, with a value of HK$101.94m. The active buy/sell ratio is 31:69,
with net selling turnover of HK$33.07m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$7.71m, with volume weighted average price of HK$39.625.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of
HK$3.37m, with volume weighted average price of HK$39.632. The stock has fallen a combined
9.88% over the past 4 consecutive trading days.
The Hang Seng Index now rose 159 points, or 0.66% to 24,403; the Hang Seng China
Enterprises Index now rose 53 points, or 0.62% to 8,556; the Hang Seng TECH Index now rose
58 points, or 1.05% to 5,611; with an overall turnover of HK$22b.
The SSE Composite Index now rose 15 points, or 0.44% to 3,448, with an overall turnover
of RMB80.15b.
The SZSE Component Index now rose 75 points, or 0.55% to 13,758, with an overall
turnover of RMB50.78b.
Basic Information
=================
----------------------------------
Nominal 38.750 % Chg -5.26%
High 42.250 Low 38.700
Shares Tr 2.56m Turnover 101.94m
10-D SMA 41.645 %H.V 68.740
20-D SMA 42.480 VWAP 39.831
50-D SMA 55.413 RSI14 32.590
----------------------------------
Status: Active buy/sell ratio is 31:69, with net selling turnover of HK$33.07m, falling a
combined 9.88% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
INNOVENT BIO (01801) 38.75 -5.26
GENSCRIPT BIO (01548) 28.00 -2.44
VIVA BIOTECH (01873) 4.06 -1.22
JUNSHI BIO (01877) 49.50 -1.59
JXR (01951) 8.05 +0.37
WUXI BIO (02269) 83.65 -2.22
TIGERMED (03347) 93.05 -2.05
BEIGENE (06160) 137.90 -3.90
CANSINOBIO-B (06185) 139.30 +0.29
REMEGEN-B (09995) 53.50 +0.28
---------------------------------------------
(ed)